Cell Theranostics
Biotechnology Research • 
Centennial, Colorado, United States • 1-10 Employees
Company overview
| Headquarters | 7120 E Orchard Rd, Centennial, Colorado 80111, US |
| Website | |
| NAICS | 541714 |
| Founded | 2015 |
| Employees | 1-10 |
| Socials |
Key Contact at Cell Theranostics
Robert Garvie
Lead Independent Director
About Cell Theranostics
Cell Theranostics is a late-stage Phase 3 biotech company specializing in the field of theranostic nuclear medicine through chelation technologies focused in cancer, cardiovascular, neuroendocrine, diabetes and ischemia-based diseases. It is the mission of Cell Theranostics to create better nuclear imaging and therapeutic agents that are affordable and accessible around the world.
$
Cell Theranostics revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Director
Funding Data
Cell Theranostics has never raised funding before.
United Kingdom
Frequently asked questions
Cell Theranostics is located in Centennial, Colorado, US.
Cell Theranostics was founded in 2015, making it 11 years old. The company has established itself as a significant player in its industry over this time.
Cell Theranostics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
